Invention Grant
- Patent Title: Triazolopyridine compounds and uses thereof
-
Application No.: US16311621Application Date: 2017-06-06
-
Publication No.: US10689378B2Publication Date: 2020-06-23
- Inventor: Ho Man Chan , Xingnian Fu , Xiang-Ju Justin Gu , Ying Huang , Ling Li , Yuan Mi , Wei Qi , Martin Sendzik , Yongfeng Sun , Long Wang , Zhengtian Yu , Hailong Zhang , Ji Yue Zhang , Man Zhang , Qiong Zhang , Kehao Zhao
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Genomics Institute of the Novartis Research Foundation
- Agent Daniel E. Raymond
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@4679b779
- International Application: PCT/IB2017/053335 WO 20170606
- International Announcement: WO2017/221092 WO 20171228
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61P35/00
Abstract:
A compound of Formula (IA), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein A, R6, R7 and R8 are as defined herein.
Public/Granted literature
- US20190202828A1 TRIAZOLOPYRIDINE COMPOUNDS AND USES THEREOF Public/Granted day:2019-07-04
Information query
